Adimab, LLC is a premier human antibody discovery and optimization company based in Lebanon, NH. With a suite of in vitro and in vivo discovery methods, as well as engineered yeast, they deliver therapeutic leads to their partners, improving and refining lead antibodies to create best-in-class molecules.
They also offer a variety of bispecific formats and utilize their proprietary platform to discover therapeutic antibodies that meet the highest standards of quality and developability. Additionally, Adimab provides a full implementation of their platform to enable partner scientists to discover and optimize lead candidates within their existing workflow.
Generated from the website